Clinical Trial Update: UNC Cashew Sublingual Immunotherapy [Phase 2]

View source ↗

Summary

UNC is conducting a Phase 2 trial evaluating sublingual immunotherapy for cashew nut allergy and tree nut allergies. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cashew Nut Allergy
• Tree Nut Allergy

Drugs mentioned

• Cashew Nut Sublingual Immunotherapy (UNC study)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cashew Nut Allergy, Tree Nut Allergies | Phase 2 | Status: NOT_YET_RECRUITING